NetworkNewsBreaks

WednesdayFeb 05, 2020 3:08 pm

NetworkNewsBreaks – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and Beijing Advaccine Partnership Featured in ROTH Equity Research Report

Inovio Pharmaceuticals (NASDAQ: INO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “INO partnered with Beijing Advaccine, a China-based company focused on discovering new preventive and therapeutic vaccines, to facilitate clinical trial initiation of INO's new coronavirus vaccine, INO-4800, in China. In our view, testing a preventative vaccine close to the source of an epidemic is a truer test of vaccine utility, and collaborating with a local partner will likely grease the wheels of commercial adoption, if successful, in a distant foreign country.” To request access to the full report, visit…

Continue Reading

WednesdayFeb 05, 2020 3:04 pm

NetworkNewsBreaks – Akoustis Technologies, Inc. (NASDAQ: AKTS) Featured in ROTH Equity Research Report

Akoustis Technologies (NASDAQ: AKTS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “AKTS will report F2Q20 (Dec.) earnings next week. We have gained increased confidence into our AKTS forecast revenue ramp for the remainder of FY20 supported by multiple programs ramping across WiFi, wireless infrastructure and military end markets. We also believe the recent fund-raising has positioned the company to execute well on its product, end market and manufacturing capacity plans. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Akoustis Technologies, Inc. Akoustis(R) is…

Continue Reading

WednesdayFeb 05, 2020 2:37 pm

NetworkNewsBreaks – Select Companies to Showcase Their Stories for Qualified Investors at 4th Annual Emerging Growth Spring Invitational

Veyo Partners together with Diamond Equity Research will host the 4th Annual Emerging Growth Spring Invitational to be held in New York City next month. A select group of small-cap companies will take the stage and showcase their stories to a highly qualified group of accredited and institutional investors at the event, slated to take place at NYC’s The Cornell Club from 5:30 to 9:00 PM on March 26, 2020. “We have hand selected a group of quality presenting companies for the Emerging Growth Spring Invitational,” Veyo Partners Senior Vice President Shane Vultee said in the news release. “Together with…

Continue Reading

WednesdayFeb 05, 2020 2:32 pm

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Direct Solar America Continues to Drive New Business as 2020 Initiatives Start to Take Shape

SinglePoint (OTCQB: SING) today announced that its subsidiary, Direct Solar America, continues to drive new business as 2020 sales and marketing initiatives start to take shape. Last week Direct Solar America experienced that increase in business with one of its biggest weeks to date in new contract development. The increase is attributed mainly to new marketing and sales development including new canvassing teams, customer service improvements and increased engagement of partnership channels. “We are strongly committed to continuing the development and improvement of Direct Solar America. The company’s model continues to impress us by the ability to scale with few…

Continue Reading

WednesdayFeb 05, 2020 1:37 pm

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Focus Clinical Efforts on Oncoprex(TM) in Combination with Osimertinib for Treatment of Non-Small Cell Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provided a clinical update and focus for its Oncoprex(TM) immunogene therapy program for 2020. According to the update, Genprex will prioritize the development of Oncoprex in combination with osimertinib for the treatment of non-small cell lung cancer (“NSCLC”). Genprex, on January 14, 2020, received U.S Food and Drug Administration (“FDA”) Fast Track Designation for its Oncoprex immunogene therapy in combination with the EGFR tyrosine kinase inhibitor osimertinib (AstraZeneca’s Tagrisso(R), currently its highest grossing product) for the…

Continue Reading

WednesdayFeb 05, 2020 1:29 pm

NetworkNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Enters Strategic Agreement with Specialty Grower QDG Agricultural

LiveWire Ergogenics (OTC: LVVV), a health and wellness company with a focus on special purpose real-estate acquisitions and the licensing and management of high-end and permitted facilities and operations to provide cannabis-based products and services in California, on Tuesday announced its entry into a definitive agreement with QDG Agricultural (“QDG”), an experienced and highly specialized cannabis production company, to begin construction for operation at its Estrella Ranch facility in Paso Robles, California. “With the demand for pure, organically grown and thoroughly tested cannabis products growing rapidly, we anticipate the handcrafted product that will be grown at our California ranch to…

Continue Reading

WednesdayFeb 05, 2020 12:31 pm

NetworkNewsBreaks – Neutra Corp. (NTRR) Secures New Round of Private Equity to Drive Vertical Integration

Neutra Corp. (OTC: NTRR) on Tuesday announced its January 1, 2020 receipt of a new round of private equity that it intends to use in its ongoing campaign to become a vertically integrated producer, manufacturer and distributor of hemp-based CBD health products. “This is a welcome event that strengthens our company and puts it in a better long-term position to compete and succeed in the marketplace,” Neutra CEO Sydney Jim said in the news release. “This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had…

Continue Reading

WednesdayFeb 05, 2020 12:22 pm

NetworkNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L) Increases Private Placement to $9M Based on Strong Interest

Standard Lithium (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L) on Tuesday announced that, owing to very strong interest, it will increase the size of its non-brokered private placement of special warrants (each, a “Special Warrant”) to accommodate the additional demand. According to the update, the Company now intends to offer up to 12,000,000 Special Warrants, each at a price of $0.75, for gross proceeds of up to $9,000,000. Standard Lithium intends to use net proceeds from the private placement to complete commissioning of its extraction demonstration plant in southern Arkansas, as well as to maintain existing property interests and for general…

Continue Reading

WednesdayFeb 05, 2020 11:24 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Host Virtual Roadshow Webinar on February 6th

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its plans to host a virtual roadshow webinar at 4:30 PM ET on Thursday, February 6, 2020. According to the update, Sigma Labs newly appointed Executive Chairman Mark K. Ruport and CEO John Rice will be presenting an overview of the market opportunity and the company's strategy to accelerate its revenue growth. The webinar will include a presentation followed with a question and answer session. Interested parties can access the webinar by visiting http://nnw.fm/Yl11t or by dialing 1-877-407-9039 or 1-201-689-8470 (International)…

Continue Reading

WednesdayFeb 05, 2020 11:19 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Innovative Culture Media for Growing Ovarian Tumor Cells in the Lab

Predictive Oncology (NASDAQ: POAI), together with its subsidiary, TumorGenesis, Inc., today announced that it has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor of its innovative culture media for growing ovarian tumor cells. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological signatures of heterogeneous ovarian cell types while growing them in the laboratory, unlike traditional cell culture media that select for one or two fast growing cell types. “Using these proprietary media our partners have identified 25 cell types from ovarian tumors, which to a large degree…

Continue Reading